KRM Ayurveda SME
smeUpcoming
GMP
₹0
smeUpcoming
KRM Ayurveda SME
Track Live GMP, Subscription Status, and Allotment Updates for this IPO.
LIVE GMP
₹0
Investment Timeline
🔓
IPO Open
19 Jan 2026
🔒
IPO Close
21 Jan 2026
🎲
Allotment
22 Jan 2026
🔔
Listing
27 Jan 2026
🤖 Smart Analysis
Educational
*AI score is algorithmic and for educational purposes only.
Algorithm Verdict
NEUTRAL
46.6/100
🎯 Application Strategy
Action: ⚠️ NEUTRAL - Mixed signals, proceed with caution
Lots: Single lot only for diversification
⏳ Timing Advice
📊 Monitor subscription trends before applying
Key Factor Analysis
🚀
Demand
🚀 Exceptional subscription! Massive oversubscription across all categories
💰
Valuation
⚠️ Moderate valuation - fairly priced but limited upside
📈
Listing
❌ Risk of listing at discount or minimal gains
📊
Financials
⚠️ Average financials - growth could be better
Issue Details
🏷️Price Band
₹128.0 - ₹135.0
📦Lot Size
1000 shares
💰Issue Size
₹71.77 Cr
🛒Retail Quota
N/A
Frequently Asked Questions
What is the current GMP of KRM Ayurveda SME?
As of today, the Grey Market Premium (GMP) for KRM Ayurveda SME is ₹0, which is approximately null of the issue price. Please note that GMP is unofficial market intelligence and subject to volatility.
What is the AI Prediction for KRM Ayurveda SME?
Our AI algorithm currently rates this IPO as "NEUTRAL" with a score of 46.6/100. This analysis is based on data patterns and is for educational purposes only, not financial advice.
When will the allotment for KRM Ayurveda SME be announced?
The allotment status for KRM Ayurveda SME is expected to be finalized on 22 Jan 2026. Investors can check their status on the registrar's website.
What is the listing date for KRM Ayurveda SME?
Shares of KRM Ayurveda SME are proposed to be listed on stock exchanges on 27 Jan 2026.
Liability Disclaimer: Ipofly.com is an informational platform. We are not SEBI registered. The information provided here (including GMP and AI analysis) is for educational purposes only and should not be considered financial advice. Investments in the stock market are subject to market risks. Please consult your financial advisor before investing.